217 related articles for article (PubMed ID: 34743173)
1. Loss of p53 suppresses replication stress-induced DNA damage in ATRX-deficient neuroblastoma.
Akter J; Katai Y; Sultana P; Takenobu H; Haruta M; Sugino RP; Mukae K; Satoh S; Wada T; Ohira M; Ando K; Kamijo T
Oncogenesis; 2021 Nov; 10(11):73. PubMed ID: 34743173
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic vulnerabilities in the DNA damage response for the treatment of ATRX mutant neuroblastoma.
George SL; Lorenzi F; King D; Hartlieb S; Campbell J; Pemberton H; Toprak UH; Barker K; Tall J; da Costa BM; van den Boogaard ML; Dolman MEM; Molenaar JJ; Bryant HE; Westermann F; Lord CJ; Chesler L
EBioMedicine; 2020 Sep; 59():102971. PubMed ID: 32846370
[TBL] [Abstract][Full Text] [Related]
3. ATM depletion induces proteasomal degradation of FANCD2 and sensitizes neuroblastoma cells to PARP inhibitors.
Parvin S; Akter J; Takenobu H; Katai Y; Satoh S; Okada R; Haruta M; Mukae K; Wada T; Ohira M; Ando K; Kamijo T
BMC Cancer; 2023 Apr; 23(1):313. PubMed ID: 37020276
[TBL] [Abstract][Full Text] [Related]
4. Functional cross talk between the Fanconi anemia and ATRX/DAXX histone chaperone pathways promotes replication fork recovery.
Raghunandan M; Yeo JE; Walter R; Saito K; Harvey AJ; Ittershagen S; Lee EA; Yang J; Hoatlin ME; Bielinsky AK; Hendrickson EA; Schärer O; Sobeck A
Hum Mol Genet; 2020 May; 29(7):1083-1095. PubMed ID: 31628488
[TBL] [Abstract][Full Text] [Related]
5. Loss of atrx cooperates with p53-deficiency to promote the development of sarcomas and other malignancies.
Oppel F; Tao T; Shi H; Ross KN; Zimmerman MW; He S; Tong G; Aster JC; Look AT
PLoS Genet; 2019 Apr; 15(4):e1008039. PubMed ID: 30970016
[TBL] [Abstract][Full Text] [Related]
6. ATRX promotes heterochromatin formation to protect cells from G-quadruplex DNA-mediated stress.
Teng YC; Sundaresan A; O'Hara R; Gant VU; Li M; Martire S; Warshaw JN; Basu A; Banaszynski LA
Nat Commun; 2021 Jun; 12(1):3887. PubMed ID: 34162889
[TBL] [Abstract][Full Text] [Related]
7. Alternative lengthening of telomeres in neuroblastoma cell lines is associated with a lack of MYCN genomic amplification and with p53 pathway aberrations.
Farooqi AS; Dagg RA; Choi LM; Shay JW; Reynolds CP; Lau LM
J Neurooncol; 2014 Aug; 119(1):17-26. PubMed ID: 24792489
[TBL] [Abstract][Full Text] [Related]
8. Regulation of Replication Stress in Alternative Lengthening of Telomeres by Fanconi Anaemia Protein.
Li D; Hou K; Zhang K; Jia S
Genes (Basel); 2022 Jan; 13(2):. PubMed ID: 35205225
[TBL] [Abstract][Full Text] [Related]
9. Loss of ATRX suppresses ATM dependent DNA damage repair by modulating H3K9me3 to enhance temozolomide sensitivity in glioma.
Han B; Cai J; Gao W; Meng X; Gao F; Wu P; Duan C; Wang R; Dinislam M; Lin L; Kang C; Jiang C
Cancer Lett; 2018 Apr; 419():280-290. PubMed ID: 29378238
[TBL] [Abstract][Full Text] [Related]
10. Atrx deficiency induces telomere dysfunction, endocrine defects, and reduced life span.
Watson LA; Solomon LA; Li JR; Jiang Y; Edwards M; Shin-ya K; Beier F; Bérubé NG
J Clin Invest; 2013 May; 123(5):2049-63. PubMed ID: 23563309
[TBL] [Abstract][Full Text] [Related]
11. Co-Inhibition of the DNA Damage Response and CHK1 Enhances Apoptosis of Neuroblastoma Cells.
Ando K; Nakamura Y; Nagase H; Nakagawara A; Koshinaga T; Wada S; Makishima M
Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31362335
[TBL] [Abstract][Full Text] [Related]
12. G-quadruplex DNA drives genomic instability and represents a targetable molecular abnormality in ATRX-deficient malignant glioma.
Wang Y; Yang J; Wild AT; Wu WH; Shah R; Danussi C; Riggins GJ; Kannan K; Sulman EP; Chan TA; Huse JT
Nat Commun; 2019 Feb; 10(1):943. PubMed ID: 30808951
[TBL] [Abstract][Full Text] [Related]
13. Suppression of the alternative lengthening of telomere pathway by the chromatin remodelling factor ATRX.
Clynes D; Jelinska C; Xella B; Ayyub H; Scott C; Mitson M; Taylor S; Higgs DR; Gibbons RJ
Nat Commun; 2015 Jul; 6():7538. PubMed ID: 26143912
[TBL] [Abstract][Full Text] [Related]
14. MRE11 inhibition highlights a replication stress-dependent vulnerability of MYCN-driven tumors.
Petroni M; Sardina F; Infante P; Bartolazzi A; Locatelli E; Fabretti F; Di Giulio S; Capalbo C; Cardinali B; Coppa A; Tessitore A; Colicchia V; Sahùn Roncero M; Belardinilli F; Di Marcotullio L; Soddu S; Comes Franchini M; Petricci E; Gulino A; Giannini G
Cell Death Dis; 2018 Aug; 9(9):895. PubMed ID: 30166519
[TBL] [Abstract][Full Text] [Related]
15. FANCM suppresses DNA replication stress at ALT telomeres by disrupting TERRA R-loops.
Pan X; Chen Y; Biju B; Ahmed N; Kong J; Goldenberg M; Huang J; Mohan N; Klosek S; Parsa K; Guh CY; Lu R; Pickett HA; Chu HP; Zhang D
Sci Rep; 2019 Dec; 9(1):19110. PubMed ID: 31836759
[TBL] [Abstract][Full Text] [Related]
16. IDH1-R132H acts as a tumor suppressor in glioma via epigenetic up-regulation of the DNA damage response.
Núñez FJ; Mendez FM; Kadiyala P; Alghamri MS; Savelieff MG; Garcia-Fabiani MB; Haase S; Koschmann C; Calinescu AA; Kamran N; Saxena M; Patel R; Carney S; Guo MZ; Edwards M; Ljungman M; Qin T; Sartor MA; Tagett R; Venneti S; Brosnan-Cashman J; Meeker A; Gorbunova V; Zhao L; Kremer DM; Zhang L; Lyssiotis CA; Jones L; Herting CJ; Ross JL; Hambardzumyan D; Hervey-Jumper S; Figueroa ME; Lowenstein PR; Castro MG
Sci Transl Med; 2019 Feb; 11(479):. PubMed ID: 30760578
[TBL] [Abstract][Full Text] [Related]
17. CDK4 inhibition restores G(1)-S arrest in MYCN-amplified neuroblastoma cells in the context of doxorubicin-induced DNA damage.
Gogolin S; Ehemann V; Becker G; Brueckner LM; Dreidax D; Bannert S; Nolte I; Savelyeva L; Bell E; Westermann F
Cell Cycle; 2013 Apr; 12(7):1091-104. PubMed ID: 23462184
[TBL] [Abstract][Full Text] [Related]
18. Novel 1p tumour suppressor Dnmt1-associated protein 1 regulates MYCN/ataxia telangiectasia mutated/p53 pathway.
Yamaguchi Y; Takenobu H; Ohira M; Nakazawa A; Yoshida S; Akita N; Shimozato O; Iwama A; Nakagawara A; Kamijo T
Eur J Cancer; 2014 May; 50(8):1555-65. PubMed ID: 24559687
[TBL] [Abstract][Full Text] [Related]
19. Loss of ATRX confers DNA repair defects and PARP inhibitor sensitivity.
Garbarino J; Eckroate J; Sundaram RK; Jensen RB; Bindra RS
Transl Oncol; 2021 Sep; 14(9):101147. PubMed ID: 34118569
[TBL] [Abstract][Full Text] [Related]
20. The chromatin remodelling factor ATRX suppresses R-loops in transcribed telomeric repeats.
Nguyen DT; Voon HPJ; Xella B; Scott C; Clynes D; Babbs C; Ayyub H; Kerry J; Sharpe JA; Sloane-Stanley JA; Butler S; Fisher CA; Gray NE; Jenuwein T; Higgs DR; Gibbons RJ
EMBO Rep; 2017 Jun; 18(6):914-928. PubMed ID: 28487353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
